CN116549533A - 一种金银花白芷茶及其制备方法 - Google Patents
一种金银花白芷茶及其制备方法 Download PDFInfo
- Publication number
- CN116549533A CN116549533A CN202310667860.XA CN202310667860A CN116549533A CN 116549533 A CN116549533 A CN 116549533A CN 202310667860 A CN202310667860 A CN 202310667860A CN 116549533 A CN116549533 A CN 116549533A
- Authority
- CN
- China
- Prior art keywords
- parts
- honeysuckle
- tea
- raw materials
- medlar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000205585 Aquilegia canadensis Species 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 241001122767 Theaceae Species 0.000 title description 44
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 55
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 21
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 21
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 21
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 21
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 21
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 21
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 21
- 240000000249 Morus alba Species 0.000 claims abstract description 20
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 20
- 240000005739 Eurycoma longifolia Species 0.000 claims abstract description 19
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 244000269722 Thea sinensis Species 0.000 claims abstract 10
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 8
- 239000000284 extract Substances 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 229920002774 Maltodextrin Polymers 0.000 claims description 16
- 239000005913 Maltodextrin Substances 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 229940035034 maltodextrin Drugs 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000000643 oven drying Methods 0.000 claims description 8
- 238000010298 pulverizing process Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 201000005569 Gout Diseases 0.000 abstract description 24
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 19
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 18
- 229940116269 uric acid Drugs 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 229940010454 licorice Drugs 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 230000009982 effect on human Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 230000008485 antagonism Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 208000001848 dysentery Diseases 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000219304 Portulacaceae Species 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000036487 Arthropathies Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000000214 effect on organisms Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种金银花白芷茶及其制备方法,所述金银花白芷茶包括如下重量份的原料:金银花30~40份、白芷20~30份、桑叶3~7份、甘草3~7份、马齿苋3~7份、枸杞子3~7份和东革阿里8~12份;本申请发明人根据中草药配伍十八反、十九畏,二十四性原则,筛选各原料,以金银花为君药,清热解毒,消炎抑菌;白芷和东革阿里为臣药,祛风燥湿,消肿止痛,降尿酸;桑叶和甘草为佐药,桑叶清热解毒,疏散风热,甘草清热解毒,补气抗炎;马齿苋和枸杞子为使药,马齿苋疏通血管,解毒止痢,枸杞子啊滋补肝肾,益精明目;经各原料配伍,使得金银花白芷茶能够快速高效的降酸排酸,溶解痛风石,对痛风具有显著疗效,疗效快,此外,各中草药为天然植物,对人体无毒副作用。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种金银花白芷茶及其制备方法。
背景技术
痛风(Gout)是一种常见且复杂的关节炎类型,各个年龄段均可能罹患本病,男性发病率高于女性。痛风患者经常会在夜晚出现突然性的关节疼,发病急,关节部位出现疼痛、水肿、红肿和炎症,疼痛感慢慢减轻直至消失,持续几天或几周不等。痛风发作与体内尿酸浓度有关,痛风会在关节腔等处形成尿酸盐沉积,进而引发急性关节疼痛。痛风是由单钠尿酸盐沉积所致的晶体相关性关节病。痛风主要包括急性发作性关节炎、痛风石形成、痛风石性慢性关节炎、尿酸盐肾病、尿酸性尿路结石、关节残疾、肾功能衰竭等症状。痛风发病的诱因主要是食用了富含大量嘌呤的食物。
对于痛风主要有药物治疗法和饮食治疗法两种方法。治疗痛风的药物主要有非甾类抗炎药、糖皮质激素,该药物对机体造成一定副作用;而饮食治疗方法是比较普遍和健康的治疗方法,减少食用高嘌呤食物、高脂类食物,如肉类、野味、海鲜、含酵母食物和饮料等;尽可能饮用随低食物可将尿酸通过尿液排出体外,但该饮食疗法效果较慢。
发明内容
本发明的目的在于提供一种金银花白芷茶及其制备方法,本发明金银花白芷茶以天然植物的原料,对人体无毒副作用,并通过各原料的共同作用,具有清热解毒、抗炎夏军、滋肝补肾等功效,能够快速高效的降酸排酸,溶解痛风石,对痛风具有显著疗效。
为了实现本发明的上述目的,特采用以下技术方案:
本发明第一方面提供了一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花30~40份、白芷20~30份、桑叶3~7份、甘草3~7份、马齿苋3~7份、枸杞子3~7份和东革阿里8~12份。
优选地,所述金银花白芷茶包括如下重量份的原料:
金银花32~38份、白芷22~28份、桑叶4~6份、甘草4~6份、马齿苋4~6份、枸杞子4~6份和东革阿里9~11份。
优选地,所述金银花白芷茶包括如下重量份的原料:
金银花32份、白芷28份、桑叶4份、甘草6份、马齿苋6份、枸杞子4份和东革阿里9份。
优选地,所述金银花白芷茶包括如下重量份的原料:
金银花38份、白芷22份、桑叶6份、甘草4份、马齿苋4份、枸杞子6份和东革阿里11份。
优选地,所述金银花白芷茶包括如下重量份的原料:
金银花35份、白芷25份、桑叶5份、甘草5份、马齿苋5份、枸杞子5份和东革阿里10份。
本发明第二方面提供了一种上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取、过滤、浓缩、烘干、粉碎,得到提取物;
(c)将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
优选地,所述水煮提取时间为4~8h。
优选地,所述烘干温度为50~80℃。
优选地,所述提取物、麦芽糊精和葡萄糖的质量比为1∶(10~20)∶(2~4)。
与现有技术相比,本发明的有益效果至少包括:
本申请发明人根据中医理论并结合多年临床经验,并根据中草药配伍十八反、十九畏,二十四性原则,筛选各原料,具体地,金银花为君药,清热解毒,消炎抑菌;白芷和东革阿里为臣药,祛风燥湿,消肿止痛,降尿酸;桑叶和甘草为佐药,桑叶清热解毒,疏散风热,甘草清热解毒,补气抗炎;马齿苋和枸杞子为使药,马齿苋疏通血管,解毒止痢,枸杞子啊滋补肝肾,益精明目;经各原料配伍,使得金银花白芷茶能够快速高效的降酸排酸,溶解痛风石,对痛风具有显著疗效,疗效快,此外,各中草药为天然植物,对人体无毒副作用。
具体实施方式
下面将结合实施例对本发明技术方案的实施例进行详细的描述。以下实施例仅用于更加清楚地说明本发明的技术方案,因此只作为示例,而不能以此来限制本发明的保护范围。
需要注意的是,除非另有说明,本申请使用的技术术语或者科学术语应当为本发明所属领域技术人员所理解的通常意义。
实施例1
本实施例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花30份、白芷30份、桑叶3份、甘草3份、马齿苋7份、枸杞子7份和东革阿里8份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取4h、过滤、浓缩,在80℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶10∶2将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
实施例2
本实施例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花40份、白芷20份、桑叶7份、甘草7份、马齿苋3份、枸杞子3份和东革阿里12份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取8h、过滤、浓缩,在50℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶20∶4将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
实施例3
本实施例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花32份、白芷28份、桑叶4份、甘草6份、马齿苋6份、枸杞子4份和东革阿里9份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取6h、过滤、浓缩,在60℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶15∶3将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
实施例4
本实施例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花38份、白芷22份、桑叶6份、甘草4份、马齿苋4份、枸杞子6份和东革阿里11份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取6h、过滤、浓缩,在60℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶15∶3将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
实施例5
本实施例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花35份、白芷25份、桑叶5份、甘草5份、马齿苋5份、枸杞子5份和东革阿里10份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取6h、过滤、浓缩,在60℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶15∶3将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
对比例1
本对比例为一种金银花白芷茶,所述金银花白芷茶包括如下重量份的原料:
金银花35份、白芷25份、甘草10份、马齿苋5份、枸杞子5份和东革阿里10份。
上述金银花白芷茶的制备方法,所述制备方法包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取6h、过滤、浓缩,在60℃下烘干、粉碎,得到提取物;
(c)按照提取物、麦芽糊精和葡萄糖的质量比为1∶15∶3将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
实验例
累计治疗149痛风患者,每位患者诊断为痛风,且尿酸含量均超出参考区间,其中,对比例1的金银花白芷茶治疗21人,实施例3的金银花白芷茶治疗33人,实施例4的金银花白芷茶治疗27人,实施例5的金银花白芷茶治疗68人;其中,对比例1和实施例3~5的金银花白芷茶每袋5g;开水冲泡饮用,每袋至少冲泡两次,每天服用3袋;
以尿酸含量评判不同金银花白芷茶的疗效,持续服用7天后,检测尿酸含量,统计尿酸含量在202~416umol/L之间内的患者数量,结果如表1所示;
表1
组别 | 患者数量(人) |
实施例3 | 16 |
实施例4 | 17 |
实施例5 | 59 |
对比例1 | 7 |
本申请发明从最初采用对比例1的金银花白芷茶进行治疗,因为短期疗效较差,后对各原料进行调整,然后,对实施例3~5中金银花白芷茶中各原料用量的依次筛选,最终得到实施例5的金银花白芷茶的疗效最显著,能够快速降低痛风患者体内尿酸含量,以及改善痛风症状。
典型病例
病例1
范某某,年龄78岁,男,诊断为痛风,尿酸含量为423umol/L,服用实施例5的金银花白芷茶7天后,再次检测尿酸含量为265umol/L,而且痛风症状显著改善。
病例2
李某,年龄59岁,男,诊断为痛风,尿酸含量为684.40umol/L,服用实施例5的金银花白芷茶7天后,再次检测尿酸含量为353umol/L。
病例3
王某某,年龄63岁,女,诊断为痛风,尿酸含量为648umol/L,服用实施例5的金银花白芷茶7天后,再次检测尿酸含量为260umol/L,而且痛风症状显著改善。
病例4
吕某某,年龄41岁,男,诊断为痛风,尿酸含量为537.3umol/L,服用实施例5的金银花白芷茶7天后,再次检测尿酸含量为268.4umol/L,而且痛风症状显著改善。
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围,其均应涵盖在本发明的权利要求和说明书的范围当中。
Claims (9)
1.一种金银花白芷茶,其特征在于,包括如下重量份的原料:
金银花30~40份、白芷20~30份、桑叶3~7份、甘草3~7份、马齿苋3~7份、枸杞子3~7份和东革阿里8~12份。
2.根据权利要求1所述的金银花白芷茶,其特征在于,包括如下重量份的原料:
金银花32~38份、白芷22~28份、桑叶4~6份、甘草4~6份、马齿苋4~6份、枸杞子4~6份和东革阿里9~11份。
3.根据权利要求1所述的金银花白芷茶,其特征在于,包括如下重量份的原料:
金银花32份、白芷28份、桑叶4份、甘草6份、马齿苋6份、枸杞子4份和东革阿里9份。
4.根据权利要求1所述的金银花白芷茶,其特征在于,包括如下重量份的原料:
金银花38份、白芷22份、桑叶6份、甘草4份、马齿苋4份、枸杞子6份和东革阿里11份。
5.根据权利要求1所述的金银花白芷茶,其特征在于,包括如下重量份的原料:
金银花35份、白芷25份、桑叶5份、甘草5份、马齿苋5份、枸杞子5份和东革阿里10份。
6.权利要求1~5任一所述的金银花白芷茶的制备方法,其特征在于,包括如下步骤:
(a)按照重量份称取各原料;
(b)将各原料置于水中进行水煮提取、过滤、浓缩、烘干、粉碎,得到提取物;
(c)将提取物中加入麦芽糊精和葡萄糖混合制粒、干燥灭菌、装袋,即得所述金银花白芷茶。
7.根据权利要求6所述的制备方法,其特征在于,所述水煮提取时间为4~8h。
8.根据权利要求6所述的制备方法,其特征在于,所述烘干温度为50~80℃。
9.根据权利要求6所述的制备方法,其特征在于,所述提取物、麦芽糊精和葡萄糖的质量比为1∶(10~20)∶(2~4)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310667860.XA CN116549533A (zh) | 2023-06-07 | 2023-06-07 | 一种金银花白芷茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310667860.XA CN116549533A (zh) | 2023-06-07 | 2023-06-07 | 一种金银花白芷茶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116549533A true CN116549533A (zh) | 2023-08-08 |
Family
ID=87501899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310667860.XA Pending CN116549533A (zh) | 2023-06-07 | 2023-06-07 | 一种金银花白芷茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116549533A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101153256A (zh) * | 2007-09-28 | 2008-04-02 | 范成连 | 金银花酒 |
CN107412612A (zh) * | 2017-04-19 | 2017-12-01 | 广西大学 | 一种保健降尿酸代用茶及其制备方法 |
CN109316566A (zh) * | 2018-11-30 | 2019-02-12 | 湖北仙芝堂生物科技有限公司 | 一种可以降尿酸代用茶的生产方法 |
-
2023
- 2023-06-07 CN CN202310667860.XA patent/CN116549533A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101153256A (zh) * | 2007-09-28 | 2008-04-02 | 范成连 | 金银花酒 |
CN107412612A (zh) * | 2017-04-19 | 2017-12-01 | 广西大学 | 一种保健降尿酸代用茶及其制备方法 |
CN109316566A (zh) * | 2018-11-30 | 2019-02-12 | 湖北仙芝堂生物科技有限公司 | 一种可以降尿酸代用茶的生产方法 |
Non-Patent Citations (3)
Title |
---|
妙峰魅莉: "这些食物早晚泡水喝,尿酸偷偷往下降,痛风人看过来!", pages 11, Retrieved from the Internet <URL:https://mp.weixin.qq.com/s/x8oeho6Vc4MAtYSQXHYyUg> * |
小雪茶供应链管理(北京)有限公司食品企业标准: "金银花白芷代用茶", pages 1 - 2, Retrieved from the Internet <URL:https://103.83.44.207:8080/spba/prophase/prophase/qqgsview.action?Stdnum =Q> * |
董文玲;: "仙方活命饮临床治验4则", 江苏中医药, vol. 40, no. 09, 5 September 2008 (2008-09-05), pages 49 - 50 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107372943B (zh) | 一种助消化预防口臭的保健茶及其制备方法和应用 | |
CN105126067A (zh) | 一种降尿酸的组合物及其用途 | |
CN1294852C (zh) | 降火滋阴饮料 | |
KR20110045140A (ko) | 부들, 조릿대, 갈대 및 줄풀을 포함하는 한방음료 | |
CN1900255A (zh) | 男性健美长寿液 | |
CN109287926A (zh) | 一种清火疗痔固体饮料及其制备方法 | |
CN105213256A (zh) | 一种舒敏祛红柔肤水及其制备方法 | |
CN103518912A (zh) | 一种治疗慢性咽炎的中药保健茶及其制备方法 | |
CN103893620B (zh) | 一种预防、治疗糖尿病的中药组合物及其制备方法 | |
CN103893613B (zh) | 一种治疗口腔溃疡的药物及制备方法 | |
CN116549533A (zh) | 一种金银花白芷茶及其制备方法 | |
CN106924581A (zh) | 一种治疗腹痛的药酒及其制备方法 | |
CN103385329A (zh) | 一种治疗老人便秘的中草药冲泡茶及其制法 | |
CN107648484A (zh) | 一种可以降尿酸的配方 | |
CN108785559B (zh) | 一种治疗呼吸道感染的药物及其制备方法 | |
CN112516262A (zh) | 一种缓解痛风的降酸茶及其制备方法 | |
CN107648335B (zh) | 调节动脉粥样硬化自噬与凋亡的中药组合物及制备方法 | |
CN101676401B (zh) | 一种蝎提取物 | |
CN113750187A (zh) | 一种加入藤黄果和玫瑰茄预防和治疗肾结石的配方 | |
CN110420320A (zh) | 一种清除痛风发病基础的中药组合物 | |
CN103340991A (zh) | 一种用于护理糖尿病患者的口服液及制备方法 | |
CN103463498A (zh) | 一种治疗咽喉炎的中药制剂 | |
CN107890493A (zh) | 一种治疗牙痛热肿的中成药剂及其制作方法 | |
CN107259032A (zh) | 一种降糖茶及其制备方法 | |
CN107998230A (zh) | 一种治疗牙龈肿痛的中药及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |